Nakamura, Seikou; Kozuka, Mutsuo; Bastow, Kenneth F.; Tokuda, Harukuni; Nishino, Hoyoku; Suzuki, Madoka; Tatsuzaki, Jin; Morris Natschke, Susan L.; Kuo, Sheng-Chu; Lee, Kuo-Hsiung published the artcile< Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters>, Application of C9H9NO4, the main research area is antitumor quinolone acridine derivative preparation SAR.
2-Phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives were synthesized and screened as potential antitumor promoters by examining the ability of the compounds to inhibit Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells. Interestingly, compounds 14, 15, and 17 showed similar inhibitory effects (89-92%, 66-69%, and 24-29% at 1000, 500, and 100 mol ratio to TPA, resp.) against EBV-EA with potencies comparable to those of glycyrrhetic acid, a known natural antitumor-promoter.
Bioorganic & Medicinal Chemistry published new progress about Antitumor agents. 30095-98-8 belongs to class esters-buliding-blocks, and the molecular formula is C9H9NO4, Application of C9H9NO4.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics